Treatment of severe psoriasis with infliximab
Summary: Infliximab is an anti-tumor necrosis factor-α monoclonal antibody shown to be effective in the treatment of moderate-to-severe psoriasis and psoriatic arthritis. We report on the first two patients in Croatia in which the efficacy of infliximab therapy was monitored and evaluated primarily...
| Permalink: | http://skupni.nsk.hr/Record/nsk.NSK01000734057 |
|---|---|
| Matična publikacija: |
Acta dermatovenerologica Croatica 17 (2009), 3 ; str. 204-208 |
| Glavni autor: | Peternel, Sandra (-) |
| Ostali autori: | Prpić Massari, Larisa (-), Guina, Tina, Novak, Srđan, liječnik, Brajac, Ines, Kaštelan, Marija |
| Vrsta građe: | Članak |
| Jezik: | eng |
| Predmet: | |
| Online pristup: |
Acta Dermatovenerologica Croatica |